173 results
Page 4 of 9
8-K
EX-99.1
ricnqg7iu0rjo60l
18 Feb 21
MedAvail Announces Preliminary Fourth Quarter and Full Year 2020 Results
12:00am
8-K
ccxkb1 q2
25 Nov 20
Changes in Registrant's Certifying Accountant
4:42pm
8-K
EX-4.1
hjm6npzlo
18 Nov 20
Report of Independent Auditors
8:00am
8-K
EX-99.2
o3s3gf d63p
18 Nov 20
Report of Independent Auditors
8:00am
8-K
bw5hd0ufcdvr
18 Nov 20
Report of Independent Auditors
8:00am
8-K
EX-10.11
f3haoqj0fnsn2c5xh1js
18 Nov 20
Report of Independent Auditors
8:00am
8-K
EX-10.14
g1ubwsp qy
18 Nov 20
Report of Independent Auditors
8:00am
8-K
EX-4.3
byn p93iep
18 Nov 20
Report of Independent Auditors
8:00am
8-K
EX-99.3
dlfr10b7
18 Nov 20
Report of Independent Auditors
8:00am
8-K
EX-10.13
ti3k 8hjw
18 Nov 20
Report of Independent Auditors
8:00am
8-K
EX-99.1
ffosg323z1o zyzc7
18 Nov 20
Report of Independent Auditors
8:00am
8-K
vwm2c1k
17 Nov 20
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
8:02am
8-K
EX-99.1
xold75b9y
17 Nov 20
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
8:02am
425
EX-99.1
jmvmap5wmhbudxd3
17 Nov 20
Business combination disclosure
8:00am
425
14vjaaemp5wi jvot
17 Nov 20
Business combination disclosure
8:00am
8-K
wqr 2xejtyi2x00853
12 Nov 20
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
4:32pm
8-K
EX-99.1
dc85s32gfraz1t47d0t
12 Nov 20
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
4:32pm
425
EX-99.1
sm3mzf8 z10
12 Nov 20
Business combination disclosure
4:30pm
425
qa6irubv
12 Nov 20
Business combination disclosure
4:30pm
8-K
ef4l nyw9o9mrov
6 Nov 20
Other Events
4:17pm